What's Happening?
Distinguished Professor Denis Nash and his team at the CUNY Institute for Implementation Science in Population Health (CUNY ISPH), in collaboration with Pfizer, conducted the 2024 study, Project PROTECTS.
This research investigated the long-term effects of various respiratory illnesses using both at-home and laboratory (PCR) testing. The study, which involved over 6,000 participants from diverse U.S. regions, focused on individuals at high risk for severe outcomes from respiratory infections. Participants were tracked daily for 30 days from symptom onset, providing detailed data on their symptoms. This project built upon a previous CUNY ISPH initiative, Project CHASING COVID, also funded by Pfizer. Project PROTECTS aimed to understand the progression of average or minor respiratory illness cases and assess the accuracy and utility of at-home testing. The study also measured the impact of antivirals on short- and long-term symptoms, with data collection concluding in the fall and analyses currently underway. Initial findings were presented at the European Society of Clinical Microbiology and Infectious Diseases global conference.
Why It's Important?
This study is crucial for enhancing future pandemic preparedness by providing a deeper understanding of respiratory illnesses beyond severe cases typically seen in medical settings. By tracking a large cohort of participants with varying illness severities, researchers can develop more comprehensive models for anticipating and responding to new pathogens. The findings on the reliability of at-home testing for different viruses, such as the 98% accuracy for COVID versus 37% for influenza B, offer valuable insights for public health strategies and consumer guidance. Furthermore, the research highlights the comparable rates of longer-term symptoms across COVID, flu, and RSV, suggesting a need for more extensive research into post-acute outcomes for non-COVID respiratory infections. The methodology employed, particularly the intensive data collection via a digital platform, sets a precedent for future large-scale, community-based participatory research, which can be rapidly adapted for emerging health threats.
What's Next?
The CUNY ISPH team is currently finalizing the robust dataset from Project PROTECTS and is actively engaged in analyses and preparing scientific papers for publication. They will complete data collection on the effects of antivirals in the fall. The researchers anticipate that the methodologies developed for this complex digital platform study can be applied to various public health questions in the future. Professor Nash expressed hope that maintaining an active test cohort will enable rapid adaptation to new pathogens, such as the bird flu, which remains a potential pandemic threat. The model established by Project PROTECTS is expected to inspire new approaches to pandemic preparedness, emphasizing the need for epidemiologists to proactively anticipate global health crises rather than merely react to them.
Beyond the Headlines
The success of Project PROTECTS in maintaining a high retention rate among over 6,000 participants, despite the intensive daily reporting requirements, underscores the potential of community-based participatory research in public health. This model fosters a collaborative environment where individuals actively contribute to scientific understanding, potentially increasing public trust and engagement in health initiatives. The study's focus on the 'average' respiratory illness experience, rather than just severe cases, addresses a significant gap in medical literature and could lead to more nuanced public health messaging and intervention strategies. Ethically, the rigorous data collection and fraud prevention measures implemented highlight the challenges and necessities of ensuring data integrity in large-scale digital health studies. The long-term implication is a shift towards more proactive, data-driven, and community-engaged approaches to public health, moving beyond reactive measures in the face of future pandemics.












